Abstract

Dental Caries affects approximately 90% of the world's population. At present, the clinical treatment for dental caries is root canal therapy. This treatment results in loss of tooth sensitivity and vitality. Tissue engineering can potentially solve this problem by enabling regeneration of a functional pulp tissue. Dental pulp stem cells (DPSCs) have been shown to be an excellent source for pulp regeneration. However, limited availability of these cells hinders its potential for clinical translation. We have investigated the possibility of using somatic mesenchymal stem cells (MSCs) from other sources for dental pulp tissue regeneration using a biomimetic dental pulp extracellular matrix (ECM) incorporated scaffold. Human periodontal ligament stem cells (PDLSCs) and human bone marrow stromal cells (HMSCs) were investigated for their ability to differentiate toward an odontogenic lineage. In vitro real-time PCR results coupled with histological and immunohistochemical examination of the explanted tissues confirmed the ability of PDLSCs and HMSCs to form a vascularized pulp-like tissue. These findings indicate that the dental pulp stem derived ECM scaffold stimulated odontogenic differentiation of PDLSCs and HMSCs without the need for exogenous addition of growth and differentiation factors. This study represents a translational perspective toward possible therapeutic application of using a combination of somatic stem cells and extracellular matrix for pulp regeneration.

Highlights

  • Dental caries is the most prevalent infectious disease among children and adults

  • In this study we have verified that the biomimetic extracellular matrix (ECM) scaffold maintains lineage specific differentiation of Dental pulp stem cells (DPSCs) over a period of 4 weeks and we have identified the odontogenic differentiation potential of other somatic stem cells such as periodontal ligament stem cells (PDLSCs) and human bone marrow stromal cells (HMSCs)

  • As a significant step toward realizing the potential of the ECM mediated pulp tissue engineering as clinical possibility, we have explored the use of PDLSCs and HMSCs for dental pulp tissue regeneration

Read more

Summary

Introduction

Dental caries is the most prevalent infectious disease among children and adults. Approximately 90% of the world’s population has experienced dental caries (Petersen et al, 2005). The pulp tissue is highly vascularized, innervated and serves as a source of stem cells. These characteristics enable the pulp to play a significant role in homeostasis and formation of reparative dentin (Schmalz and Galler, 2011). Current clinical treatment for dental caries is root canal therapy. This involves the cleaning and replacement of the infected and necrotic pulp tissue with a mineral trioxide compound. As a result of replacing a living tissue with a trioxide compound, the tooth looses its vitality and sensitivity and it is prone to secondary infections and the complications associated with it (Cordeiro et al, 2008). Root canal treatment poses an even greater problem by preventing root maturation (Lentzari and Kozirakis, 1989; McTigue et al, 2013)

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call